Skip to content
Review Open access

Zika virus Pathogenesis and Targeted Intervention Strategies

Oct 2026 · Viruses · Vol 18 · 0 citations · 190 references
Medicine

TL;DR

The molecular mechanisms by which multiple ZIKV proteins synergistically regulate pathogenic processes are summarized and the current research basis and response strategies for flavivirus ADE are reviewed, and unresolved scientific questions are outlined.

Abstract

Zika virus (ZIKV), a mosquito-borne member of the Flaviviridae family, is primarily transmitted via the bite of Aedes aegypti mosquitoes but can also be spread through sexual contact and vertical transmission. Infection with ZIKV causes Zika fever and Guillain–Barré syndrome (GBS); more importantly, maternal infection during pregnancy can result in severe neurodevelopmental disorders, such as fetal microcephaly. Although the World Health Organization declared the Zika outbreak a Public Health Emergency of International Concern (PHEIC) in 2016, and extensive research has since been conducted, no approved vaccines or therapeutic drugs are currently available. Recent studies have shown that various ZIKV-encoded proteins participate in host-barrier breaching, regulation of tissue tropism, interference with neurodevelopment, mediation of neurotoxicity, and evasion of type I interferon (IFN-I) immune responses, thereby advancing the development of vaccines and antiviral drugs targeting viral proteins. However, the complete mechanisms by which viral proteins synergistically mediate pathogenesis, the clinical significance of antibody-dependent enhancement (ADE) and its prevention and control strategies, and the practical barriers to clinical translation of protein-targeted interventions have not been systematically elucidated. This review is structured around viral proteins as a central framework: it summarizes the molecular mechanisms by which multiple ZIKV proteins synergistically regulate pathogenic processes; reviews the current research basis and response strategies for flavivirus ADE, and outlines unresolved scientific questions; and discusses progress in vaccines and antiviral drugs targeting viral proteins, with emphasis on evidence gaps and clinical translation barriers. By integrating existing findings and unresolved scientific questions, this review provides a research-gap-oriented theoretical reference for basic ZIKV research and clinical translation of prevention and control strategies.

Read PDF

Similar papers

Review Open access Sep 2026

Zika Virus Pathogenesis and Therapeutic Prospects: Molecular Mechanisms, Neurological Implications, and Emerging Antiviral Scaffolds

A comprehensive overview of ZIKV pathogenesis, transmission routes, and molecular mechanisms underlying host–virus interactions is provided, with emphasis on structural and functional insights into key viral enzymes NS2B–NS3 protease and NS5 RNA-dependent RNA polymerase which serve as pivotal antiviral drug targets.

Arvind Kumar, Harpreet Singh, Sagar Varshney et al. · 0 citations
Open access Sep 2026

Evaluation of a Zika virus-like particle-based vaccine in a highly penetrant non-human primate model of congenital infection

A highly pathogenic nonhuman primate pregnancy model is evaluated for its ability to assess vaccine-mediated protection using a Zika virus-like particle (VLP) vaccine as a test platform and results support a high risk of early pregnancy loss following African-lineage ZIKV-DAK 41524 infection in RM.

Hannah K. Jaeger, Jessica L. Smith, C. Labriola et al. · 0 citations
Review Open access Jan 2026

Vertical Transmission of Zika Virus: The Immune–Pathophysiological Interface of the Placenta

The mechanisms by which ZIKV infects placental cells through the engagement of specific cellular receptors such as AXL and T‐cell immunoglobulin and mucin while simultaneously evading host immune defenses are examined to inform the development of future therapeutic strategies aimed at preventing fetal transmission.

Carla de Fátima Silva Menezes, L. Martins, G. Ferro et al. · 0 citations
Review Open access Sep 2026

Molecular Mechanisms of Zika Virus Entry into Host Cells

The World Health Organization classifies mosquito-borne viruses as a major global public health threat with pandemic risk and urges all nations to strengthen pandemic preparedness. As a representative mosquito-borne flavivirus, ZIKV bears prominent pandemic capacity. Its distinctive neurotropic property and capability...

Hao-Long Cong, Xin Zhao, Wen-Hui Li et al. · 0 citations
Review Open access Oct 2026

An overview of current technologies in the development of drugs and vaccines against dengue virus.

Current research aims to elucidate the complex host immune responses that underlie dengue pathogenesis and vaccine-induced protection, to develop more effective treatments and preventive measures.

Masoud Pourzangiabadi, Morteza Barkam, Hamideh Najafi et al. · 0 citations
Review Open access Sep 2026

Zika virus and host innate immunity: mechanisms of activation and evasion

This Review summarizes current knowledge of how the innate immune system recognizes ZIKV and how the virus counteracts these responses, while highlighting unresolved questions and potential therapeutic targets.

Dan-Yu Qian, Yu-Lei Guo, Ai-Xin Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.